Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,806 institutions that hold shares in the stock, with a total of 239 Million shares, which have been reported (via 13F filing form) to have a value of $92.5 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Capital World Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
28,732,143
shares
|
$11.1 Billion
1.94% of portfolio
|
Q2 2025
Added 0.7%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
23,973,777
shares
|
$9.3 Billion
0.18% of portfolio
|
Q2 2025
Added 2.05%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,312,244
shares
|
$8.26 Billion
0.23% of portfolio
|
Q2 2024
Reduced 2.95%
|
|
Capital Research Global Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
16,108,291
shares
|
$6.25 Billion
1.5% of portfolio
|
Q2 2025
Added 10.81%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
11,775,227
shares
|
$4.57 Billion
0.2% of portfolio
|
Q2 2025
Reduced 0.11%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
7,755,645
shares
|
$3.01 Billion
0.29% of portfolio
|
Q1 2025
Added 22.85%
|
|
Jennison Associates LLC
|
Aug 01, 2025 Q2 2025 |
6,151,505
shares
|
$2.39 Billion
1.64% of portfolio
|
Q2 2025
Added 21.51%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
5,928,747
shares
|
$2.3 Billion
0.19% of portfolio
|
Q2 2025
Added 2.9%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,813,386
shares
|
$1.87 Billion
0.41% of portfolio
|
Q2 2025
Reduced 11.76%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
4,378,320
shares
|
$1.7 Billion
0.67% of portfolio
|
Q2 2025
Added 10.75%
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
3,813,378
shares
|
$1.48 Billion
2.2% of portfolio
|
Q2 2025
Added 1.74%
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
3,580,356
shares
|
$1.39 Billion
0.21% of portfolio
|
Q2 2025
New holding
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
3,331,439
shares
|
$1.29 Billion
0.1% of portfolio
|
Q2 2025
Reduced 2.26%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
3,159,870
shares
|
$1.23 Billion
0.16% of portfolio
|
Q2 2025
Added 8.32%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
3,067,473
shares
|
$1.19 Billion
0.29% of portfolio
|
Q2 2025
Added 19.85%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,807,617
shares
|
$1.09 Billion
0.09% of portfolio
|
Q2 2025
Reduced 2.0%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
2,658,581
shares
|
$1.03 Billion
0.17% of portfolio
|
Q2 2025
Added 1.5%
|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
2,635,903
shares
|
$1.02 Billion
0.21% of portfolio
|
Q2 2025
Added 305.59%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,619,534
shares
|
$1.02 Billion
0.6% of portfolio
|
Q2 2025
Reduced 4.67%
|
|
Edgewood Management LLC
Greenwich, CT |
Aug 13, 2025 Q2 2025 |
2,454,947
shares
|
$952 Million
3.48% of portfolio
|
Q2 2025
Reduced 7.15%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
2,181,362
shares
|
$846 Million
0.25% of portfolio
|
Q2 2025
Reduced 2.42%
|
|
Victory Capital Management Inc
|
Aug 13, 2025 Q2 2025 |
2,155,164
shares
|
$836 Million
0.66% of portfolio
|
Q2 2025
Added 633.34%
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
1,984,046
shares
|
$769 Million
0.16% of portfolio
|
Q2 2025
Added 7.5%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,931,760
shares
|
$749 Million
0.12% of portfolio
|
Q2 2025
Added 11.37%
|
|
Legal & General Group PLC
London, X0 |
Aug 12, 2025 Q2 2025 |
1,889,777
shares
|
$733 Million
0.22% of portfolio
|
Q2 2025
Reduced 0.23%
|